Fig. 7From: Development and validation of a new LC–MS/MS method for the determination of mefatinib in human plasma and its first application in pharmacokinetic studiesThe predicted and measured time-concentration profiles after multiple dosing of MET306 in 105 and 140 mg groupsBack to article page